ASK REDCHAT ANYTHING ABOUT COYA THERAPEUTICS INC.
Coya Therapeutics Inc. (NASDAQ: COYA)
Listen to this Section
$4.60
-0.2690
(
-5.52% )
156.6K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| COYA 301 [Low Dose Interleukin-2 (LD IL-2)]DetailsAlzheimer's disease, Neurodegenerative disease |
Phase 2 |
Market Data
|
| Open |
$4.60 |
| Previous Close |
$4.87 |
| Volume |
156.6K |
| Market Cap |
$108.84M |
| Day Range |
$4.59 - $5.10 |
| 52 Week Range |
$3.71 - $7.75 |
| Shares Outstanding |
23.46M |
| Change % |
-5.52% |
| Net Change |
▼ -0.2690 |
| Insider Ownership |
-0.02% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Year | 2022 |
| Country | United States |
| Underwriter | Chardan Capital Markets, Newbridge Securities, Joseph Gunnar, more |
Insider Ownership Transactions
Total Amount Purchased:
-687,663.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2024-02-02 |
Sale |
-81819.00 |
Grossman Fred |
| 2024-01-19 |
Sale |
-5000.00 |
Garren Hideki |
| 2024-01-19 |
Sale |
-5000.00 |
GOLDSTEIN DOV A MD |
| 2024-01-19 |
Sale |
-5000.00 |
Weinand Dieter |
| 2024-01-19 |
Sale |
-5000.00 |
Lee Ann |
| 2024-01-19 |
Sale |
-5000.00 |
Villalobos Anabella |
| 2024-01-04 |
Sale |
-10000.00 |
ROSS WILBUR L JR |
| 2023-08-21 |
Sale |
-10000.00 |
Weinand Dieter |
SEC Filings
| Form Type |
Description |
Pages |
Date |
| 10-q |
Quarterly Reports |
56 |
Nov 12, 2025 |
| 8-k |
8K-related |
11 |
Nov 12, 2025 |
| 8-k |
8K-related |
17 |
Oct 27, 2025 |
| 8-k |
8K-related |
12 |
Sep 02, 2025 |
| 4 |
Insider transactions |
1 |
Aug 19, 2025 |
| 10-q |
Quarterly Reports |
55 |
Aug 12, 2025 |
| 8-k |
8K-related |
11 |
Aug 12, 2025 |
| 8-k |
8K-related |
12 |
Jul 29, 2025 |
| 8-k |
8K-related |
12 |
Jul 01, 2025 |
| 8-k |
8K-related |
12 |
Jun 26, 2025 |